Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

OBJECTIVE This investigation was undertaken to clarify the neuropathological substrates of key psychiatric symptoms in dementia with Lewy bodies. METHOD The authors studied 112 autopsy-confirmed cases of dementia with Lewy bodies in patients who had had annual standardized clinical evaluations until their death. The relationships of persistent psychiatric symptoms (visual hallucinations, delusions, depression) to plaques (Consortium to Establish a Registry for Alzheimer's Disease protocol), tangles (Braak staging), and Lewy bodies (consensus Lewy body staging) were evaluated. In addition, symptom frequency and persistent symptoms were compared in the patients with Lewy body dementia and 90 patients with autopsy-confirmed Alzheimer's disease studied prospectively during life. RESULTS The main neuropathological correlate of persistent visual hallucinations was the presence of less severe tangle pathology, but there was no significant association between tangle pathology and persistent delusions. Lewy body staging was associated with the presence of persistent visual hallucinations and persistent delusions. All baseline psychiatric features were significantly more frequent in dementia with Lewy bodies than in Alzheimer's disease, as were persistent visual hallucinations, but patients who had dementia with Lewy bodies and severe tangle pathology had a clinical symptom profile more similar to that of Alzheimer's disease patients and were less likely to have neocortical Lewy bodies. CONCLUSIONS The modest proportion of patients with Lewy body dementia and more severe tangle pathology resembled Alzheimer's disease patients clinically. Unlike Alzheimer's disease, dementia with Lewy bodies showed a significant inverse association between tangle burden and psychosis.

[1]  D. Salmon,et al.  Clinical and Neuropathological Findings in Lewy Body Dementias , 1996, Brain and Cognition.

[2]  K. Kosaka,et al.  Relationship in the formation process between neurofibrillary tangles and Lewy bodies in the hippocampus of dementia with Lewy bodies brains , 2002, Journal of the Neurological Sciences.

[3]  Vladimir Hachinski,et al.  Clinical and Pathologic Features of Two Groups of Patients With Dementia With Lewy Bodies: Effect of Coexisting Alzheimer-Type Lesion Load , 2001, Alzheimer disease and associated disorders.

[4]  J. Miller,et al.  Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. , 2000, Archives of general psychiatry.

[5]  R. Levy,et al.  The Lewy-Body Variant of Alzheimer's Disease , 1993, British Journal of Psychiatry.

[6]  V. A. Kral,et al.  Clinical Value of the London Psychogeriatric Rating Scale , 1978, Journal of the American Geriatrics Society.

[7]  Hersch El Development and application of the extended scale for dementia. , 1979 .

[8]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: clinical features in 15 cases. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[9]  Mary Johnson,et al.  Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus , 1993, Hippocampus.

[10]  R. Schiffer,et al.  Psychiatric features in diffuse Lewy body disease , 1996, Neurology.

[11]  B. Hyman,et al.  Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies , 1999, Neurology.

[12]  G. Halliday,et al.  Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. , 2002, Brain : a journal of neurology.

[13]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[14]  C. Pieper,et al.  Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease , 1999, Neurology.

[15]  M. Esiri,et al.  Accuracy of Clinical Operational Diagnostic Criteria for Alzheimer’s Disease in Relation to Different Pathological Diagnostic Protocols , 1998, Dementia and Geriatric Cognitive Disorders.

[16]  M. Albert,et al.  An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. , 2001, Archives of neurology.

[17]  E. Perry,et al.  Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. , 1999, The American journal of psychiatry.

[18]  D. Dickson,et al.  Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease , 1991, Neurology.

[19]  M. Esiri,et al.  Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[20]  P. Thompson,et al.  The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. , 2001, The Journal of clinical psychiatry.

[21]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[22]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[23]  E. Perry,et al.  Delusions associated with elevated muscarinic binding in dementia with Lewy bodies , 2000, Annals of neurology.

[24]  K. Davis,et al.  Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. , 2000, Archives of neurology.

[25]  G. Alexopoulos,et al.  Cornell scale for depression in dementia , 1988, Biological Psychiatry.

[26]  L. Honig,et al.  Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. , 1996, The American journal of psychiatry.

[27]  J. Grace,et al.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.

[28]  E. Perry,et al.  A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. , 2002, Journal of affective disorders.

[29]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[30]  B. Hyman,et al.  α-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining , 2000, Acta Neuropathologica.

[31]  K. Marder,et al.  The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.

[32]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[33]  Kazuko Aoto,et al.  Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies , 1999, Brain Research.

[34]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[35]  J. Copeland,et al.  Computerized diagnosis from a standardized history schedule: A preliminary communication about the organic section of the HAS–AGECAT system , 1992 .

[36]  J. Growdon,et al.  Clinical and quantitative pathologic correlates of dementia with Lewy bodies , 1999, Neurology.